Latest Period
Q2 2026
Security Snapshot
KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS) Institutional Ownership
CUSIP: G52441105
13F Institutional Holders and Ownership History from Q1 2025 to Q2 2026
Institutions Reporting
108
Shares (Excl. Options)
58,728,853
Price
$25.44
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- KMTS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 58,728,853
- Total 13F value
- $1,485,953,563
- Portfolio coverage rank
- 0%
- Share change
- +296,094
- Value change
- +$8,209,123
- Number of holders
- 108
- Shares outstanding
- 58,457,647
- SEC-reported price per share
- $27.90
- Insider filing price
- $27.90
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK is tracked under CUSIP G52441105.
- 108 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 101 to 108 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,173,262,884 to $1,485,953,563.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 108 institutions filings for Q2 2026.
Security key
G52441105
Latest holder period
Q2 2026
13F holders
108
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
KMTS full holder history
KESTRA MEDICAL TECHNOLOGIES, LTD. SEC filings
KESTRA MEDICAL TECHNOLOGIES, LTD. company facts
KESTRA MEDICAL TECHNOLOGIES, LTD. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G52441105:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
KMTS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bain Charger Holdings, L.P. | 43% | -18% | $554,798,330 | -$40,705,389 | 25,172,338 | -6.8% | Bain Charger Holdings, L.P. | 31 Dec 2025 |
| FMR LLC | 10% | +65% | $96,158,179 | +$38,804,570 | 5,225,988 | +68% | FMR LLC | 30 Sep 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 8.5% | -17% | $123,029,964 | -$24,754,157 | 4,968,900 | -17% | T. Rowe Price Associates, Inc. | 30 Jun 2026 |
| Endeavour Medtech Growth II LP | 4.2% | -20% | $53,974,682 | -$4,362,972 | 2,448,942 | -7.5% | Endeavour Medtech Growth II LP | 31 Dec 2025 |
As of 30 Jun 2026, 108 institutional investors reported holding 58,728,853 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS). This represents 100% of the company’s total 58,457,647 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
97%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bain Capital Investors LLC | 43% | 25,172,338 | 0% | 13% | $640,384,279 |
| FMR LLC | 9.4% | 5,523,647 | -3.5% | 0.01% | $140,521,580 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 8.5% | 4,968,900 | -17% | 0.01% | $126,410,000 |
| ANDERA PARTNERS | 4.7% | 2,728,679 | +1.2% | 34% | $69,417,594 |
| Yu Fan | 3.9% | 2,282,519 | 0% | 54% | $58,067,283 |
| BROWN ADVISORY INC | 3.3% | 1,909,056 | +11% | 0.08% | $48,566,391 |
| BlackRock, Inc. | 3.2% | 1,865,496 | +10% | 0% | $47,458,217 |
| ALLIANCEBERNSTEIN L.P. | 2.5% | 1,477,992 | +12% | 0.01% | $29,456,381 |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.5% | 1,446,742 | +0.06% | 0.49% | $36,804,970 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2% | 1,175,525 | -3.1% | 0% | $29,905,356 |
| FRANKLIN RESOURCES INC | 1.9% | 1,123,622 | -9.6% | 0.01% | $28,584,956 |
| Omega Fund Management, LLC | 1.7% | 1,022,149 | 0% | 14% | $26,003,471 |
| Hood River Capital Management LLC | 1.3% | 753,529 | +15% | 0.14% | $19,169,778 |
| STATE STREET CORP | 1.3% | 747,703 | +11% | 0% | $19,021,564 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 647,380 | +13% | 0% | $16,472,464 |
| Point72 Asset Management, L.P. | 0.9% | 526,626 | 0.02% | $13,397,365 | |
| FEDERATED HERMES, INC. | 0.9% | 525,000 | 0% | 0.02% | $13,356,000 |
| NEXT CENTURY GROWTH INVESTORS LLC | 0.78% | 458,505 | +0.21% | 0.62% | $11,664,367 |
| Driehaus Capital Management LLC | 0.77% | 448,608 | +0.29% | 0.07% | $11,412,588 |
| UBS Group AG | 0.56% | 325,838 | -6.8% | 0% | $8,289,318 |
| GOLDMAN SACHS GROUP INC | 0.52% | 304,384 | +5.6% | 0% | $7,743,529 |
| Schonfeld Strategic Advisors LLC | 0.49% | 286,231 | +151% | 0.04% | $7,281,714 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.44% | 255,329 | +17% | 0% | $6,495,570 |
| SEI INVESTMENTS CO | 0.41% | 240,043 | +1.2% | 0.01% | $6,106,694 |
| NORTHERN TRUST CORP | 0.36% | 208,225 | +8.7% | 0% | $5,297,244 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
Q2 2026
Rows shown
1-6 of 6
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 58,728,853 | $1,485,953,563 | +$8,209,123 | $25.44 | 108 |
| 2026 Q1 | 58,434,462 | $1,173,262,884 | +$30,753,131 | $19.93 | 101 |
| 2025 Q4 | 56,150,806 | $1,489,190,179 | +$139,802,244 | $26.52 | 108 |
| 2025 Q3 | 48,395,709 | $1,149,884,732 | +$50,205,342 | $23.76 | 79 |
| 2025 Q2 | 47,375,461 | $785,486,291 | +$35,826,645 | $16.58 | 73 |
| 2025 Q1 | 44,838,936 | $1,117,387,025 | +$1,117,073,033 | $24.92 | 63 |